Alyeska Investment Group
ARAV

Alyeska Investment Group’s Aravive, Inc. Common Stock ARAV Stock Holding History

Alyeska Investment Group’s Portfolio ARAV Stock Details ARAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-34,167
Closed -$2.51M – 570
2016
Q3 		$2.51M Buy
+34,167
New +$2.47M 0.02% 374

Other funds holding ARAV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group's ARAV Position: Q4 2016 in Review

Alyeska Investment Group sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2016, closing a stake of 34,167 shares — an estimated $2.51M sold.

Alyeska Investment Group first reported a position in ARAV in Q3 2016 and held it in 1 quarter. The position peaked at $2.51M in Q3 2016. 75 funds tracked by Wall St. Rank hold ARAV as of Q4 2016.

  • Alyeska Investment Group reported no remaining Aravive, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 34,167 Aravive, Inc. Common Stock shares in Q4 2016, an estimated $2.51M.
  • Alyeska Investment Group first reported a position in Aravive, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
  • Alyeska Investment Group's Aravive, Inc. Common Stock position peaked at $2.51M in Q3 2016.
  • 75 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2016.

Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.